BofA lowered the firm’s price target on Herbalife to $8 from $10 and keeps an Underperform rating on the shares after the company introduced Q1 and 2024 guidance with wide ranges. The firm is lowering 2024 estimates due to higher expenses and expects the company to deliver at the lower end of its range due to muted sales growth and higher SG&A costs.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HLF:
- Herbalife Announces Restructuring, Executive Changes, and Financial Outlook
- Herbalife Announces Board Member Resignation and Appointment
- Fly Insider: Exelixis, Akami among week’s notable insider trades
- Herbalife CEO Michael Johnson purchases 61,725 shares at $8.07
- Herbalife put volume heavy and directionally bearish
